Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression-Reference-Cited by-同舟云学术

Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression

Published:2017-11-09 Issue:2 Volume:118 Page:213-223
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Kashiwagi Eiji,Inoue Satoshi,Mizushima Taichi,Chen Jinbo,Ide Hiroki,Kawahara Takashi,Reis Leonardo O,Baras Alexander S,Netto George J,Miyamoto Hiroshi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2017393.pdf

Reference57 articles.

1. Abbosh PH, McConkey DJ, Plimack ER (2015) Targeting signaling transduction pathways in bladder cancer. Curr Oncol Rep 17: 58.

2. Abramovitz M, Adam M, Boie Y, Carrière M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, Belley M, Gallant M, Dufresne C, Gareau Y, Ruel R, Juteau H, Labelle M, Ouimet N, Metters KM (2000) The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 483: 285–293.

3. Altorki NK, Keresztes R, Port J, Libby D, Korst R, Flieder D, Ferrara CA, Yankelevitz DF, Subbaramaiah K, Pasmantier MW, Dannenberg AJ (2003) Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non–small-cell lung cancer. J Clin Oncol 21: 2645–2650.

4. Aoki T, Nishimura M, Matsuoka T, Yamamoto K, Furuyashiki T, Kataoka H, Kitaoka S, Ishibashi R, Ishibazawa A, Miyamoto S, Morishita R, Ando J, Hashimoto N, Nozaki K, Narumiya S (2011) PGE2-EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB. Br J Pharmacol 163: 1237–1249.

5. Arjona-Sánchez Á, Ruiz-Rabelo J, Perea MD, Vázquez R, Cruz A, Muñoz Mdel C, Túnez I, Muntané J, Padillo FJ (2010) Effects of capecitabine and celecoxib in experimental pancreatic cancer. Pancreatology 10: 641–647.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors;Cancer Research Communications;2023-08-08

2. Effect of celecoxib plus standard chemotherapy on cancer prognosis: A systematic review and meta‐analysis;European Journal of Clinical Investigation;2023-03

3. Exosomal miR-93-5p as an important driver of bladder cancer progression;Translational Andrology and Urology;2023-02

4. Systemic Oncospheres: Host Inflammation and Cancer;Tumor Ecosystem;2023

5. Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer;Seminars in Cancer Biology;2022-11